Mansour Miky, M.D. Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 1414 W Fair Ave, Suite 204, Marquette, MI 49855 Phone: 906-225-7740 |
Dr. Carl F Eiben, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 850 West Baraga Avenue Suite #30, Marquette, MI 49855 Phone: 906-225-3914 Fax: 906-225-4583 |
John Michael Coyne, M.D. Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 580 W College Ave, Marquette, MI 49855 Phone: 906-225-3914 Fax: 906-225-4583 |
Dr. Louis Ostola, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 850 West Baraga Avenue Suite 30, Marquette, MI 49855 Phone: 906-225-3914 Fax: 906-225-4583 |
Dr. Richard E Vermeulen, MD Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 580 W College Ave, Marquette, MI 49855 Phone: 906-225-4575 |
Dr. Frederick M Maynard Jr., M.D. Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 580 W College Ave, Skywalk, Marquette, MI 49855 Phone: 906-225-3914 Fax: 906-225-4583 |
Eric Peter Sturos, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 850 W Baraga Ave Ste 30, Marquette, MI 49855 Phone: 906-225-3914 Fax: 906-225-4583 |
News Archive
Pharmaron has signed an agreement to provide Isis Pharmaceuticals, Inc. with nucleoside phosphoramidites at quantities up to 100 kg. Nucleoside phosphoramidites are fundamental building blocks in the production of antisense therapeutics.
The American Red Cross Southeastern Michigan Blood Services Region is issuing an urgent appeal for blood donors. Recent extraordinary patient needs and consistent low donor turnout this month have caused the local blood supply to drop to critically low levels.
A neonatologist at The Children's Hospital of Philadelphia is the senior author of a large new study that found that current non-invasive techniques for respiratory support are less effective than widely assumed, in reducing the incidence of severe lung injury in very premature infants.
​Technology that hampers mosquitoes' host-seeking behavior, identified at the University of California, Riverside in 2011, has led to the development of the world's first product that blocks mosquitoes' ability to efficiently detect carbon dioxide, their primary method of tracking human blood meals.
First-String Research, Inc. (FSR), a spin-off biotechnology company from the Medical University of South Carolina (MUSC), has begun the human clinical trial process for its unique, wound-healing peptide gel.
› Verified 5 days ago